Te Pātaka Whaioranga - Pharmac has initiated consultation today to fund ustekinumab (branded as Stelara) for people with inflammatory bowel disease (IBD) and to widen access to infliximab (branded as Remicade) for IBD-associated arthritis
New research from the University of Otago, released today, has shown the level of harm our tamariki are exposed to through outdoor marketing of gambling, alcohol and junk food
Te Whatu Ora – Health New Zealand and Manatū Hauora – Ministry of Health have confirmed two new cases of Monkeypox as at 5 October 2022, since the 9 cases notified in the 28 September update
Source
Media release from Te Whatu Ora - Health New Zealand
The exponential growth in specialist vape retailers across New Zealand over the last 12 months is something we should be concerned about says the Asthma and Respiratory Foundation’s Chief Executive Letitia Harding
Source
Media release from the Asthma and Respiratory Foundation NZ
General Practice New Zealand (GPNZ) today welcomed Health Minister Andrew Little’s announcement today that the Government is putting more money into GP training
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes